SRHQ
SRH U.S. Quality ETF
SRHQ tracks an equally weighted index of US large-cap stocks screened based on three fundamental factors: value, growth, and quality.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 195.7 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Oct 05, 2022 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| CENTENE CORP | 2.0 % |
| UNITEDHEALTH GROUP INC | 1.6 % |
| HUMANA INC | 1.6 % |
| STERLING CONSTRUCTION CO | 1.6 % |
| FRONTDOOR, INC. | 1.6 % |
| COMMVAULT SYSTEMS INC | 1.5 % |
| ELEVANCE HEALTH INC | 1.5 % |
| EMCOR GROUP INC | 1.5 % |
| CREDIT ACCEPTANCE CORP | 1.4 % |
| RESIDEO TECHNOLOGIES, INC. | 1.4 % |
Constituent Breakdown
| Number of holdings | 81 |
| Herfindahl-Hirschman Index | 128 |
| Wgt avg mkt cap (mns) | $33,301 |
| Large cap (>$10bn) | 55.8% |
| Mid cap ($2-10bn) | 38.1% |
| Small cap (<$2bn) | 3.4% |
| Developed mkts. | 99.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 99.8 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 12.3% | 22.8% | 15.2% | 17.8% | -- | -- | -- | 16.3% |
| Dividend Yield | 0.2% | 1.0% | 0.9% | 0.9% | -- | -- | -- | 0.9% |
| Total Returns | 12.5% | 23.8% | 16.1% | 18.7% | -- | -- | -- | 17.2% | Ann. Volatility | 15.9% | 14.7% | 16.8% | 15.7% | -- | -- | -- | 16.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.93 | 56% |
| MSCI EAFE | 0.63 | 41% |
| MSCI Emg Mkts | 0.41 | 30% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.40% |
Technical Indicators
| 30d moving avg. (EMA) | $43.29 |
| Relative strength (RSI) | 61 |
| MACD/Signal | 0.32/0.25 |
| Bollinger Bands (Upper/Lower) | $44.40/$42.63 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. SRHQ |
Expenses vs. SRHQ |
ALTAR Score™ vs. SRHQ |
|---|---|---|---|---|
| DSTL | Distillate US Fundamental Stability & Value ETF | 23.1% | +4 bp | +1.8% |
| RNMC | First Trust Mid Cap US Equity Select ETF | 16.6% | +25 bp | +0.6% |
| FSCS | First Trust SMID Capital Strength ETF | 16.3% | +25 bp | +1.3% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 15.8% | +5 bp | +0.3% |
| FCFY | First Trust S&P 500 Diversified Free Cash Flow ETF | 15.6% | +25 bp | +2.9% |
| USMF | WisdomTree U.S. Multifactor Fund | 14.6% | -7 bp | +0.2% |
| XHS | State Street SPDR S&P Health Care Services ETF | 14.5% | 0 bp | -2.7% |
| ECML | Euclidean Fundamental Value ETF | 14.1% | +60 bp | +2.5% |
| FLOW | Global X U.S. Cash Flow Kings 100 ETF | 13.0% | -10 bp | +4.5% |
| COWZ | Pacer US Cash Cows 100 ETF | 12.8% | +14 bp | +1.3% |
Risk and Returns: SRHQ vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
7.0%
ALTAR SCORE™
79th
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,399 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. SRHQ's ALTAR Score™ is approximately 0.8 standard
deviations above the category average. This places SRHQ in the 79th percentile
among funds in the category.
Sell-Side Consensus
$55
PRICE TARGET
+23.8%
UPSIDE